Patients with high levels of CA9 mRNA in the tumor tissue had a median overall survival of 11 months post-diagnosis compared to patients with low CA9 mRNA level who had a median overall survival of 42 months (Kaplan–Meier–analysis (p = 0.038)). The gene discussed is CA9; the disease is neoplasm.